References
- Gillmore JD, Damy T, Fontana M, et al. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018;39(30):2799–2806. doi: 10.1093/eurheartj/ehx589.
- Grogan M, Scott CG, Kyle RA, et al. Natural history of Wild-Type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. J Am Coll Cardiol. 2016;68(10):1014–1020. doi: 10.1016/j.jacc.2016.06.033.
- Kumar S, Dispenzieri A, Lacy MQ, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012;30(9):989–995. doi: 10.1200/JCO.2011.38.5724.
- Bishop E, Brown EE, Fajardo J, et al. Seven factors predict a delayed diagnosis of cardiac amyloidosis. Amyloid. 2018;25(3):174–179. doi: 10.1080/13506129.2018.1498782.
- Kittleson MM, Ruberg FL, Ambardekar AV, et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023;81(11):1076–1126. doi: 10.1016/j.jacc.2022.11.022.
- Sattianayagam PT, Hawkins PN, Gillmore JD. Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol. 2009;6(10):608–617. doi: 10.1038/nrgastro.2009.147.
- Dahiya DS, Kichloo A, Singh J, et al. Gastrointestinal amyloidosis: a focused review. World J Gastrointest Endosc. 2021;13(1):1–12. doi: 10.4253/wjge.v13.i1.1.
- Sperry BW, Reyes BA, Ikram A, et al. Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. J Am Coll Cardiol. 2018;72(17):2040–2050. doi: 10.1016/j.jacc.2018.07.092.
- Sperry BW, Khedraki R, Gabrovsek A, et al. Cardiac amyloidosis screening at trigger finger release surgery. Am J Cardiol. 2021;160:96–98. doi: 10.1016/j.amjcard.2021.08.049.